Tasmi (40mg) 14 Tablets
Product Highlights
- Lowering blood pressure
- Treatment of hypertension
- Reduce the risk of stroke
- Reduce the risk of death after a stroke
- Reduce the risk of heart attack
- Reduce the risk of kidney damage as a result of diabetes
- Reduce vision loss as a result of diabetes
- Reduce risk of cardiovascular mortality
- Reduce the risk of diabetic nephropathy
- Treat arterial hypertensive disorders
- Treatment of hypertension in pregnant women, and women who are breastfeeding
- May be used with diuretics or calcium channel blockers to treat hypertension.
₨ 442.00
2 in stock
Add to wishlist Add to compareAsk about productDescription
Angiotensin II receptor type 1 (AT1) antagonists like Telmisartan are selective and orally active. They reduce end organ responses to angiotensin II by inhibiting the AT1 receptor. This reduces total peripheral resistance and cardiac venous return. The effects of angiotensin-converting enzyme (ACE) inhibitors like nitric oxide (NO) generation, vasodilation, antiproliferative effects, and anti-inflammatory effects are also mediated via the AT1 receptor inhibition. Telmisartan is a lipophilic drug that crosses the blood-brain barrier and reaches higher concentrations in the brain than hydrophilic drugs. Unlike ACE inhibitors, angiotensin II receptor antagonists do not have sexual dimorphism with regard to pharmacokinetics.
Additional information
| Brand | Getz Pharma |
|---|---|
| Form | Tablets |
| Strength | 40 MG |
Reviews
There are no reviews yet.